Detalles de la búsqueda
1.
In vivo effects of zoledronic acid on peripheral gammadelta T lymphocytes in early breast cancer patients.
Cancer Immunol Immunother
; 58(1): 31-8, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18458903
2.
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome.
Clin Cancer Res
; 14(13): 4219-24, 2008 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18594003
3.
Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients.
Clin Cancer Res
; 13(15 Pt 1): 4482-6, 2007 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17671133
4.
Survey on learning needs and preferred sources of information to meet these needs in Italian oncology patients receiving chemotherapy.
Eur J Oncol Nurs
; 12(2): 120-6, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18294913
5.
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients.
J Interferon Cytokine Res
; 25(3): 144-51, 2005 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15767788
6.
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients.
Clin Cancer Res
; 9(8): 2893-7, 2003 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12912933
7.
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6.
J Interferon Cytokine Res
; 23(11): 649-54, 2003 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-14651779
8.
S-adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury.
Anticancer Res
; 23(6D): 5173-9, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-14981985
9.
Meeting information needs on cancer-related fatigue: an exploration of views held by Italian patients and nurses.
Support Care Cancer
; 15(11): 1231-1241, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17375340
10.
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan.
Pharmacogenomics
; 8(4): 319-27, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17391070
11.
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients.
Oncology
; 69(1): 27-34, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16088232
Resultados
1 -
11
de 11
1
Próxima >
>>